{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:32:45Z","timestamp":1793377965003,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109076","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:22:35Z","timestamp":1785738155000},"page":"109076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["De-escalation of inhaled corticosteroids and other maintenance asthma therapies in dupilumab-treated patients with severe asthma: a real-world study"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1796-8478","authenticated-orcid":false,"given":"Matteo","family":"Bonato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ciresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Savoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Talia","family":"Gaccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Dalla Libera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Turrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-9104","authenticated-orcid":false,"given":"Marco","family":"Stellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Sonego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Emanuelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7383-1487","authenticated-orcid":false,"given":"Marco","family":"Caminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-3216","authenticated-orcid":false,"given":"Gianenrico","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.109076_bib1","series-title":"Global Strategy for Asthma Management and Prevention","year":"2024"},{"key":"10.1016\/j.rmed.2026.109076_bib2","series-title":"A Short GINA Guide for Healthcare Professionists","article-title":"2024 difficult-to-treat & severe asthma in adolescents and adults diagnosis and management","year":"2024"},{"issue":"11","key":"10.1016\/j.rmed.2026.109076_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/all.13874","article-title":"Oral corticosteroid use, morbidity and mortality in asthma: a nationwide prospective cohort study in Sweden","volume":"74","author":"Ekstr\u00f6m","year":"2019","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2026.109076_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jaip.2020.10.014","article-title":"Oral corticosteroid use in asthma: a wolf in sheep's clothing","volume":"9","author":"Fuhlbrigge","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.rmed.2026.109076_bib5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/02770903.2019.1705333","article-title":"Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma","volume":"58","author":"Bourdin","year":"2021","journal-title":"J. Asthma"},{"issue":"9","key":"10.1016\/j.rmed.2026.109076_bib6","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.jaip.2023.05.044","article-title":"Impact of initiating biologics in patients with severe asthma on long-term oral corticosteroids or frequent rescue steroids (GLITTER): data from the international severe asthma registry","volume":"11","author":"Chen","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.rmed.2026.109076_bib7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/pch\/pxab015","article-title":"Adrenal suppression from exogenous glucocorticoids: recognizing risk factors and preventing morbidity","volume":"26","author":"Ahmet","year":"2021","journal-title":"Paediatr. Child Health"},{"issue":"7","key":"10.1016\/j.rmed.2026.109076_bib8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jaip.2025.01.023","article-title":"Use of high-dose inhaled corticosteroids and risk of corticosteroid-related adverse events in asthma findings from the NORDSTAR cohort","volume":"13","author":"von B\u00fclow","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.rmed.2026.109076_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaip.2018.01.025","article-title":"Inhaled corticosteroids safety and adverse effects in patients with asthma","volume":"6","author":"Heffler","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"10423","key":"10.1016\/j.rmed.2026.109076_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.rmed.2026.109076_bib11","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221212","article-title":"Type 2 inflammation and biological therapies in asthma: targeted medicine taking flight","volume":"220","author":"Howell","year":"2023","journal-title":"J. Exp. Med."},{"issue":"26","key":"10.1016\/j.rmed.2026.109076_bib12","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.rmed.2026.109076_bib13","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109076_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2026.109076_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109076_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chest.2023.10.046","article-title":"Clinical response and remission in patients with severe asthma treated with biologic therapies","volume":"165","author":"Hansen","year":"2024","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2026.109076_bib17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.rmed.2006.04.015","article-title":"The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of cochrane systematic reviews","volume":"100","author":"Adams","year":"2006","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109076_bib18","first-page":"203","article-title":"Adherence to inhalers in patients with severe asthma treated with anti-interleukin-5 biologics","volume":"46","author":"Granda","year":"2022","journal-title":"Farm. Hosp."},{"issue":"3","key":"10.1016\/j.rmed.2026.109076_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.chest.2020.10.050","article-title":"Adherence to asthma biologics: implications for patient selection, step therapy, and outcomes","volume":"159","author":"Maddux","year":"2021","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2026.109076_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/23120541.00017-2020","article-title":"Low adherence to inhaled corticosteroids\/long-acting \u03b22-agonists and biologic treatment in severe asthmatics","volume":"6","author":"Caminati","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2026.109076_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108198","article-title":"ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up","volume":"245","author":"Pini","year":"2025","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.109076_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2147\/JAA.S472490","article-title":"Benralizumab: effectiveness in patients with uncontrolled severe eosinophilic asthma at 6 and 12 months at a third-level care hospital. Capacity for ICS-LABA therapy reduction","volume":"17","author":"Gonz\u00e1lez-Tuyub","year":"2024","journal-title":"J. Asthma Allergy"},{"issue":"5","key":"10.1016\/j.rmed.2026.109076_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02259-2019","article-title":"Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma","volume":"55","author":"d'Ancona","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.109076_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cea.13491","article-title":"Mechanisms of dupilumab","volume":"50","author":"Harb","year":"2020","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2026.109076_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.109076_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.anai.2023.08.609","article-title":"Consensus of an American college of allergy, asthma, and immunology, American academy of allergy, asthma, and immunology, and American thoracic society workgroup on definition of clinical remission in asthma on treatment","volume":"131","author":"Blaiss","year":"2023","journal-title":"Ann. Allergy Asthma Immunol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:37:17Z","timestamp":1793374637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126004440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S0954611126004440"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109076","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De-escalation of inhaled corticosteroids and other maintenance asthma therapies in dupilumab-treated patients with severe asthma: a real-world study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109076"}}